 pentostatin durabl remiss hairi cell leukemia fifti patient hairi cell leukemia pentostatin dcf median month patient complet remiss CR patient partial remiss PR overal respons rate maxim respons mainten therapi median durat follow-up month patient CR patient PR dcf therapi durabl long-term disease-fre surviv patient hairi cell leukemia